Bridges Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Buy
7,514
+1,990
+36% +$523K 0.03% 191
2026
Q1
$1.47M Hold
5,524
0.02% 214
2025
Q4
$1.39M Hold
5,524
0.02% 213
2025
Q3
$1.59M Hold
5,524
0.02% 205
2025
Q2
$1.45M Sell
5,524
-22
-0.4% -$5.36K 0.02% 206
2025
Q1
$1.29M Hold
5,546
0.02% 213
2024
Q4
$1.27M Sell
5,546
-1
-0% -$229 0.02% 183
2024
Q3
$1.24M Sell
5,547
-485
-8% -$107K 0.02% 179
2024
Q2
$1.23M Buy
+6,032
New +$1.23M 0.02% 172
2019
Q4
Sell
-10,669
Closed -$1.54M 338
2019
Q3
$1.54M Buy
10,669
+640
+6% +$93.4K 0.06% 154
2019
Q2
$1.49M Buy
10,029
+2,031
+25% +$283K 0.06% 152
2019
Q1
$1.05M Buy
7,998
+3,412
+74% +$420K 0.04% 185
2018
Q4
$498K Buy
+4,586
New +$614K 0.02% 251

Other funds holding LH

Bridges Investment Management's LH Position: Q2 2026 in Review

Bridges Investment Management increased its Labcorp (LH) stake by 36% in Q2 2026, buying an estimated $523K and bringing the position to 7,514 shares worth $2.1M. The position accounts for 0.03% of the portfolio, ranked #191.

Bridges Investment Management first reported a position in LH in Q4 2018 and has held it in 13 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Bridges Investment Management held 7,514 shares of Labcorp worth $2.1M as of Q2 2026.
  • Bridges Investment Management bought 1,990 Labcorp shares in Q2 2026, an estimated $523K.
  • Labcorp made up 0.03% of Bridges Investment Management's portfolio in Q2 2026, its #191 holding.
  • Bridges Investment Management first reported a position in Labcorp in Q4 2018 and has held it in 13 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Bridges Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.